Ryo Arakane

Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study.

F. Takeshita, T. Nakayama, Katsuyasu Ishida, 2015, Vaccine.

Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial.

F. Takeshita, H. Nakatani, T. Nakayama, 2015, Vaccine.